Your browser doesn't support javascript.
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.
Begley, C Glenn; Ashton, Mark; Baell, Jonathan; Bettess, Michael; Brown, Michael P; Carter, Brett; Charman, William N; Davis, Christopher; Fisher, Simon; Frazer, Ian; Gautam, Anand; Jennings, Michael P; Kearney, Philip; Keeffe, Eloise; Kelly, Darren; Lopez, Angel F; McGuckin, Michael; Parker, Michael W; Rayner, Craig; Roberts, Brett; Rush, James S; Sullivan, Mark.
  • Begley CG; 7 Grieve Parade, Altona, Victoria, Australia.
  • Ashton M; UniQuest Pty Ltd., University of Queensland, Brisbane, Queensland, Australia.
  • Baell J; Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
  • Bettess M; Brandon Capital Partners, Melbourne, Victoria, Australia.
  • Brown MP; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Carter B; Bioseer Pty Ltd., Glen Iris, Victoria, Australia.
  • Charman WN; Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
  • Davis C; Institute for Glycomics, Griffith University, Gold Coast campus, Queensland, Australia.
  • Fisher S; Novartis Pharmaceuticals Australia Pty Ltd., Macquarie Park, New South Wales, Australia.
  • Frazer I; University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia.
  • Gautam A; Pfizer, Melbourne, Victoria, Australia.
  • Jennings MP; Institute for Glycomics, Griffith University, Gold Coast campus, Queensland, Australia.
  • Kearney P; Merck Sharp & Dohme, Macquarie Park, New South Wales, Australia.
  • Keeffe E; Institute for Glycomics, Griffith University, Gold Coast campus, Queensland, Australia.
  • Kelly D; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
  • Lopez AF; Centre for Cancer Biology, Adelaide, South Australia, Australia.
  • McGuckin M; University of Melbourne, Parkville, Victoria, Australia.
  • Parker MW; Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Rayner C; Certara, Parkville, Victoria, Australia.
  • Roberts B; Novartis Pharmaceuticals Australia Pty Ltd., Macquarie Park, New South Wales, Australia.
  • Rush JS; Novartis Pharmaceuticals AG, Basel, Switzerland.
  • Sullivan M; Medicines Development for Global Health, Southbank, Victoria, Australia.
Sci Transl Med ; 13(612): eabd5524, 2021 Sep 22.
Article in English | MEDLINE | ID: covidwho-1488280
ABSTRACT
Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often, however, there is insufficient consideration by academic researchers of the processes required to ensure that a repurposed drug can be used for a new indication. This may explain the inability of drug repurposing to fulfill its promise. Important aspects, often overlooked, include financial and intellectual property considerations, the clinical and regulatory path, and clinical equipoise, which provides ethical justification for randomized controlled trials. The goal of drug repurposing is to obtain a new regulator-approved label for an existing drug, and so, the trajectory for drug repurposing and traditional drug development is similar. Here, we discuss factors critical for a successful repurposed medicine to help academic investigators better identify drug repurposing opportunities.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Repositioning Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Sci Transl Med Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Scitranslmed.abd5524

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Repositioning Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Sci Transl Med Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Scitranslmed.abd5524